NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-72.1%
5Y CAGR-23.8%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-72.1%/yr
Annual compound
5Y CAGR
-23.8%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.43 | -66.9% |
| 2024 | 7.33 | +30.1% |
| 2023 | 5.63 | -94.9% |
| 2022 | 111.47 | -44.3% |
| 2021 | 200.21 | +2020.9% |
| 2020 | 9.44 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |